We invite you to the SOLACI@SCAI Joint Symposia to be held during the next SOLACI Sessions | April 6 thru 8, 2016 in La Habana, Cuba. Venue: Palace of Congress – La Habana – Cuba Date: Friday, April 8, 2016 Time: 11:15 AM- 12:30 PM Program Co-Chairmen: Dr. Mauricio Cohen (United States) – Dr. Jorge...
Original Title: DISSECT: A New Approach to Categorization of Aortic Dissection. Reference: M.D. Dabe, et al. Eur J Vasc Endovasac Surg 2013;46:175-90 Courtesy of Dr. Carlos Fava Interventional Cardiologist Favaloro Foundation – Argentina Aortic dissection is a lethal disease, especially in its first stages. The current classification systems (DeBakey 1965 and Stanford 1970) are widely used...
Original Title: Outcomes of anatomical versus functional testing for coronary artery disease. Presenter: Douglas PS. Early this year, the PROMISE trial was not able to confirm that testing patients with chest painusingcomputed tomography angiography (CTA) instead of functional tests, affects clinical outcomes, even though several sub analysis are currently suggesting other additional benefits,including enhanced diagnostic...
Though the benefit of FFR (fractional flow reserve) over angiography is statistically important only over the first 2 years, this pattern is maintained at long term according to FAME 5 year follow up, presented at the ECS and simultaneously published in The Lancet. Between the second and fifth year, the number of patients at risk...
JSHD | JOURNAL OF STRUCTURAL HEART DISEASE The scope of the Journal of Structural Heart Disease includes all adults with structural and congenital heart diseases, including imaging related to interventional therapies in structural and congenital heart disease. Principal subjects of the journal include the aortic valve, the aortic arch, the mitral valve, the left atrial...
The aim of this study was to evaluate treatment with alirocumab a monoclonal antibody against PCSK9 receptor, compared with placebo in patients with heterozygous familial hypercholesterolemia or high cardiovascular risk who were at the maximum tolerated dose of statins and LDL >70 mg/dl. A total of 2341 patients randomized to 150 mg alirocumab administered subcutaneously...
The new generation drug-eluting everolimus or biolimus stents have proved superior to the first generation. However, neo intimal proliferation and late thrombosis remains a problem not yet solved same for all drug-eluting stents. The Absorb (Abbott Vascular, Abbott Park, IL, USA) is the first absorbable vascular support approved for clinical use. The EVERBIO II study...
There is no strong evidence in the literature that the polymer type isolated (permanent or degradable) influences clinical outcomes after angioplasty and if the time of double anti-aggregation should be different with the degradable polymer. This work, with non-inferiority design, aimed to compare the sirolimus-eluting biodegradable polymer stent (Tivoli) versus the permanent polymer sirolimus-eluting stent...
This randomized, controlled, multicenter and blind study compared the second generation of bio-absorbable stent platform with the everolimus-eluting Xience. 501 patients were randomized 2: 1 (Absorb / Xience) with de novo lesions in native coronary arteries with a reference diameter between 2.25 and 3.8 mm estimated by quantitative angiography. All the patients underwent IVUS and...
Review: Two hundred twenty-four patients in a surgical plan, (coronary artery bypass grafting or valve), were randomized to cardiac surgery alone or associated with atrial ablation, (MAZE, 97% for cryoablation). The primary objective was the evaluation of sinus rhythm at 1 year by performing a Holter. The difference was 60.2% versus 35.5% in favor of...